Results 201 to 210 of about 13,819 (234)
Some of the next articles are maybe not open access.

Ribosome-inactivating proteins from plants

Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
L, Barbieri, M G, Battelli, F, Stirpe
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

Ribosome-inactivating Proteins from Phytolaccaceae

2014
The plant family Phytolaccaceae is a rich source of ribosome-inactivating proteins (RIPs), including the first characterized non-toxic type 1 RIP, pokeweed antiviral protein from the plant Phytolacca americana. The antiviral property is important because of its potential for defense against plant pathogens, obviously plant viruses being a key issue ...
Parente A   +4 more
openaire   +1 more source

Ribosome-Inactivating Proteins

1999
Jensen, Anders Bøgh   +3 more
openaire   +1 more source

Enzymatic Activities of Ribosome-Inactivating Proteins

2010
Ribosome-inactivating proteins (RIPs) constitute a diverse group of proteins that share an RNA N-glycosidase activity that acts very specifically on the ribosomal RNA of the 50S/60S ribosomal subunit to inhibit protein synthesis. Additionally, the majority of RIPs act on non-ribosomal RNA and DNA in a sequence context-independent fashion, releasing ...
openaire   +1 more source

Genes encoding ribosome-inactivating proteins

Plant Molecular Biology Reporter, 1994
John Mundy   +4 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera   +2 more
exaly  

Home - About - Disclaimer - Privacy